\begin{thebibliography}{}

\bibitem[Avant {\em et~al.}(2018)Avant, Wharton, and Murphy]{Avant2018}
Avant, D., Wharton, G.~T., and Murphy, D. (2018).
\newblock {Characteristics and Changes of Pediatric Therapeutic Trials under
  the Best Pharmaceuticals for Children Act}.
\newblock {\em Journal of Pediatrics\/}, {\bf 192}, 8--12.

\bibitem[Brunner {\em et~al.}(2020)Brunner, Abud-Mendoza, Viola, {Calvo
  Penades}, Levy, Anton, and et~al.]{Brunner2020}
Brunner, H.~I., Abud-Mendoza, C., Viola, D.~O., {Calvo Penades}, I., Levy, D.,
  Anton, J., and et~al. (2020).
\newblock {Safety and efficacy of intravenous belimumab in children with
  systemic lupus erythematosus: results from a randomised, placebo-controlled
  trial}.
\newblock {\em Annals of the Rheumatic Diseases\/}, {\bf 79}(10), 1340 LP --
  1348.

\bibitem[Greenberg {\em et~al.}(2018)Greenberg, Gamel, Bloom, Bradley, Jafri,
  Hinton, Nambiar, Wheeler, Tiernan, Smith, Roberts, and
  Benjamin]{Greenberg2018}
Greenberg, R.~G., Gamel, B., Bloom, D., Bradley, J., Jafri, H.~S., Hinton, D.,
  Nambiar, S., Wheeler, C., Tiernan, R., Smith, P.~B., Roberts, J., and
  Benjamin, D.~K. (2018).
\newblock {Parents' perceived obstacles to pediatric clinical trial
  participation: Findings from the clinical trials transformation initiative}.
\newblock {\em Contemporary Clinical Trials Communications\/}, {\bf 9}, 33--39.

\bibitem[Spiegelhalter {\em et~al.}(1994)Spiegelhalter, Freedman, and
  Parmar]{Spiegelhalter1994}
Spiegelhalter, D.~J., Freedman, L.~S., and Parmar, M. K.~B. (1994).
\newblock {Bayesian Approaches to Randomized Trials}.
\newblock {\em Journal of the Royal Statistical Society. Series A (Statistics
  in Society)\/}, {\bf 157}(3), 357.

\bibitem[{U.S. Food and Drug Administration}(2018){U.S. Food and Drug
  Administration}]{FDA127912}
{U.S. Food and Drug Administration} (2018).
\newblock BenlystaÂ® multi-disciplinary review and evaluation.
\newblock {\em [accessed 4/1/2020]\/}.

\end{thebibliography}
